RT Journal Article
SR Electronic
A1 Mosley, Mary
T1 Prognostic Factors Identified in Stage IV NSCLC
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 8
SP 16
OP 17
DO 10.1177/1559897715588466
UL http://mdc.sagepub.com/content/15/8/16.2.abstract
AB Single-organ metastasis and a low TN status (especially in combination), limited local metastasis, and active anticancer treatment are prognostic for a longer overall survival in patients with stage IV non–small cell lung cancer, according to a retrospective analysis using the National Cancer Registry in The Netherlands. Overall survival is longer in patients whose disease is staged using 18-fluoro-deoxyglucose positron emission tomography imaging.